Nick is a Senior Statistician at Quantics Biostatistics. He supports clients across GxP studies, bioassay design, and clinical and non-clinical study analysis. His previous work included time at Ipsen Biopharm and Sanofi, with experience in biologics and small molecules. He holds an MSc in Data Science and AI and a BSc in Neuroscience.
What are the most important properties of a new drug? Ultimately, we want to ensure that any new therapy treats what it is designed to treat—that it’s effective—and that... read more →